Dana Pizzuti Sells 9,583 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stock

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) insider Dana Pizzuti sold 9,583 shares of Crinetics Pharmaceuticals stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $34.57, for a total transaction of $331,284.31. Following the completion of the transaction, the insider now directly owns 5,911 shares of […]

Related Keywords

Canada ,China ,Dana Pizzuti ,News Ratings For Crinetics Pharmaceuticals Daily ,Quarter For Crinetics Pharmaceuticals ,Osaic Holdings Inc ,Jpmorgan Chase Co ,Jefferies Financial Group ,China Universal Asset Management Co ,Tower Research Capital ,Royal Bank ,Institutional Investors Weigh In On Crinetics Pharmaceuticals ,Securities Exchange Commission ,Crinetics Pharmaceuticals Price Performance ,Crinetics Pharmaceuticals Inc ,Cantor Fitzgerald ,Crinetics Pharmaceuticals ,Nasdaq ,Get Free Report ,Exchange Commission ,Universal Asset Management ,Research Capital ,Amalgamated Bank ,Financial Group ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,